We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Technique Allows Genome Sequencing of Single Malaria Cells

By LabMedica International staff writers
Posted on 18 May 2014
Print article
Image: Graphic of the malaria parasite Plasmodium in a red
blood cell (Photo courtesy of Simon Levey).
Image: Graphic of the malaria parasite Plasmodium in a red
blood cell (Photo courtesy of Simon Levey).
A recently developed technique for analyzing the genome of a malaria parasite within a single red blood cell is expected to aid in the understanding of the molecular cell biology of these organisms and in the design of new drugs to prevent their growth and spread.

Investigators at the Texas Biomedical Research Institute (San Antonio, USA) combined advanced cell sorting technology and whole-genome amplification (WGA) to generate high-quality DNA samples from parasite-infected red blood cells (RBCs) for genotyping and next-generation sequencing. They optimized this approach through analysis of more than 260 single-cell assays, and quantified accuracy by decomposing mixtures of known parasite genotypes and obtaining highly accurate (> 99%) single-cell genotypes.

The investigators applied this validated approach directly to infections of two major malaria species, Plasmodium falciparum, for which long term culture is possible, and Plasmodium vivax, for which no long-term culture is feasible. They demonstrated that the single-cell genomics approach could be used to generate parasite genome sequences directly from patient blood in order to unravel the complexity of P. vivax and P. falciparum infections.

Malaria parasite infections are complex and often contain multiple different parasite genotypes and even different parasite species. "This has really limited our understanding of malaria parasite biology" said senior author Dr. Ian Cheeseman, a postdoctoral scientist in the genetics department of the Texas Biomedical Research Institute. “It is like trying to understand human genetics by making DNA from everyone in a village at once. The data is all jumbled up – what we really want is information from individuals. We are now able to look at malaria infections with incredible detail. This will help us understand how to best design drugs and vaccines to tackle this major global killer.”

The study describing the novel single-cell approach for genome sequencing was published in the May 8, 2014, online edition of the journal Genome Research.

Related Links:

Texas Biomedical Research Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more